https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Neurochirurgie 2006 Dec;52(6):555-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Neurochirurgie 2006 Dec;52(6):555-702006-12-01 00:00:002019-02-15 08:59:55[Dendritic cells and gliomas: a hope in immunotherapy?]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Nat. Immunol. 2006 Dec;7(12):1299-308
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Nat. Immunol. 2006 Dec;7(12):1299-3082006-12-01 00:00:002019-02-15 09:17:43Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / Int. J. Hematol. 2006 Dec;84(5):449-58
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / Int. J. Hematol. 2006 Dec;84(5):449-582006-12-01 00:00:002019-02-15 08:48:21Combined use of dendritic cells enhances specific antileukemia immunity by leukemia cell-derived heat shock protein 70 in a mouse model with minimal residual leukemia cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-12-01 / J Clin Apher 2006 Dec;21(4):233-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-12-01 / J Clin Apher 2006 Dec;21(4):233-402006-12-01 00:00:002019-02-15 08:32:37Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-28 / Cancer Immunol. Immunother. 2007 Jul;56(7):1025-36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-28 / Cancer Immunol. Immunother. 2007 Jul;56(7):1025-362006-11-28 00:00:002019-02-15 08:38:12Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-28 / Zhonghua Yi Xue Za Zhi 2006 Nov;86(44):3122-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-28 / Zhonghua Yi Xue Za Zhi 2006 Nov;86(44):3122-72006-11-28 00:00:002006-11-28 00:00:00[Immune response of heparinase gene modified dendritic cell-based vaccine on gastric cancer cells]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-15 / Cancer Immunol. Immunother. 2007 Jun;56(6):897-903
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-15 / Cancer Immunol. Immunother. 2007 Jun;56(6):897-9032006-11-15 00:00:002019-02-15 09:16:59Antigen-independent immune responses after dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-15 / Int. J. Cancer 2006 Nov;119(10):2428-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-15 / Int. J. Cancer 2006 Nov;119(10):2428-342006-11-15 00:00:002019-02-15 09:24:12Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / Gan To Kagaku Ryoho 2006 Nov;33(12):1739-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / Gan To Kagaku Ryoho 2006 Nov;33(12):1739-412006-11-01 00:00:002019-02-15 08:44:38[Successful immunotherapy combined with hyperthermia therapy for cancer patients]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-11-01 / Neurosurgery 2006 Nov;59(5):988-99; discussioin 999-1000
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-11-01 / Neurosurgery 2006 Nov;59(5):988-99; discussioin 999-10002006-11-01 00:00:002021-11-15 15:39:05Dendritic cell vaccination in patients with malignant gliomas: current status and future directions
